Approval · Notice of Compliance 151 · 2003
ALPHAGAN P: Notice of Compliance 151
Issued November 4, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 151
- Date
- November 4, 2003
- Company
- Allergan IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Elevated intraocular pressure therapy (relatively selective alpha2-adrenoceptor agonist)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALPHAGAN P | 02248151 | Marketed |
Medicinal ingredients
- BRIMONIDINE TARTRATE 0.15 PER